Eloxx Pharmaceuticals, Inc. - ELOX
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 14
Latest filed: Jun 17, 2026
| Form | Count |
|---|---|
| 4 | 11 |
| SCHEDULE 13G | 2 |
| 8-K | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Jun 17, 2026 | 4 | Jun 10, 2026 | 0000919574-26-004021 | View |
| Jun 10, 2026 | 4 | Jun 08, 2026 | 0001193125-26-266279 | View |
| Jun 10, 2026 | 4 | Jun 08, 2026 | 0001193125-26-266278 | View |
| Jun 10, 2026 | 4 | Jun 08, 2026 | 0001193125-26-266276 | View |
| Jun 10, 2026 | 4 | Jun 10, 2026 | 0001193125-26-266277 | View |
| Jun 10, 2026 | 4 | Jun 08, 2026 | 0001193125-26-266275 | View |
| Jun 05, 2026 | 4 | May 27, 2026 | 0000919574-26-003845 | View |
| May 29, 2026 | 4 | May 27, 2026 | 0001104659-26-068440 | View |
| May 08, 2026 | 4 | Sep 19, 2025 | 0001193125-26-214983 | View |
| May 08, 2026 | 4 | Feb 06, 2022 | 0001193125-26-214890 | View |
| May 08, 2026 | 4 | Sep 19, 2025 | 0001193125-26-214815 | View |
| May 04, 2026 | SCHEDULE 13G | — | 0000919574-26-002620 | View |
| May 01, 2026 | 8-K | Apr 28, 2026 | 0001193125-26-201408 | View |
| May 01, 2026 | SCHEDULE 13G | — | 0001104659-26-054311 | View |